{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-cancer mechanisms", "anti-inflammatory", "anti-oxidative", "bioactive compounds", "chemotherapy", "haematological cancers"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37511797", "DateRevised": {"Year": "2023", "Month": "08", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "06", "Day": "21"}], "Language": ["eng"], "ELocationID": ["1422", "10.3390/life13071422"], "Journal": {"ISSN": "2075-1729", "JournalIssue": {"Volume": "13", "Issue": "7", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "21"}}, "Title": "Life (Basel, Switzerland)", "ISOAbbreviation": "Life (Basel)"}, "ArticleTitle": "Bioactive Phytoconstituents and Their Therapeutic Potentials in the Treatment of Haematological Cancers: A Review.", "Abstract": {"AbstractText": ["Haematological (blood) cancers are the cancers of the blood and lymphoid forming tissues which represents approximately 10% of all cancers. It has been reported that approximately 60% of all blood cancers are incurable. Despite substantial improvement in access to detection/diagnosis, chemotherapy and bone marrow transplantation, there is still high recurrence and unpredictable but clearly defined relapses indicating that effective therapies are still lacking. Over the past two decades, medicinal plants and their biologically active compounds are being used as potential remedies and alternative therapies for the treatment of cancer. This is due to their anti-oxidant, anti-inflammatory, anti-mutagenic, anti-angiogenic, anti-cancer activities and negligible side effects. These bioactive compounds have the capacity to reduce proliferation of haematological cancers via various mechanisms such as promoting apoptosis, transcription regulation, inhibition of signalling pathways, downregulating receptors and blocking cell cycle. This review study highlights the mechanistic and beneficial effects of nine bioactive compounds (quercetin, ursolic acid, fisetin, resveratrol, epigallocatechin gallate, curcumin, gambogic acid, butein and celastrol) as potential remedies for chemoprevention of haematological cancers. The study provides useful insights on the effectiveness of the use of bioactive compounds from plants for chemoprevention of haematological cancers."]}, "AuthorList": [{"Identifier": ["0000-0002-1393-1416"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, College of Science and Technology, Covenant University, Ota PMB 1023, Ogun State, Nigeria."}, {"Identifier": [], "Affiliation": "Covenant Applied Informatics and Communication African Centre of Excellence (CApIC-ACE), Covenant University, Ota PMB 1023, Ogun State, Nigeria."}], "LastName": "Iweala", "ForeName": "Emeka J", "Initials": "EJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Ladoke Akintola University of Technology, Ogbomoso PMB 4000, Oyo State, Nigeria."}], "LastName": "Oluwapelumi", "ForeName": "Adurosakin E", "Initials": "AE"}, {"Identifier": ["0000-0002-1713-3999"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, College of Science and Technology, Covenant University, Ota PMB 1023, Ogun State, Nigeria."}], "LastName": "Dania", "ForeName": "Omoremime E", "Initials": "OE"}, {"Identifier": ["0000-0003-3145-5473"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Abia State University, Uturu PMB 2000, Abia State, Nigeria."}], "LastName": "Ugbogu", "ForeName": "Eziuche Amadike", "Initials": "EA"}], "GrantList": [{"GrantID": "00000000", "Agency": "Covenant University Centre for Research Innovation and Discovery (CUCRID)", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Life (Basel)", "NlmUniqueID": "101580444", "ISSNLinking": "2075-1729"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Anderson K.C., Alsina M., Atanackovic D., Biermann J.S., Chandler J.C., Costello C., Djulbegovic B., Fung H.C., Gasparetto C., Godby K. NCCN guidelines insights: Multiple myeloma, version 3.2016. J. Nat. Compr. Cancer Netw. 2016;14:389\u2013400. doi: 10.6004/jnccn.2016.0046.", "ArticleIdList": ["10.6004/jnccn.2016.0046", "PMC6016087", "27059188"]}, {"Citation": "M\u00e9ndez-Ferrer S., Bonnet D., Steensma D.P., Hasserjian R.P., Ghobrial I.M., Gribben J.G., Andreeff M., Krause D.S. Bone marrow niches in haematological malignancies. Nat. Rev. Cancer. 2020;20:285\u2013298. doi: 10.1038/s41568-020-0245-2.", "ArticleIdList": ["10.1038/s41568-020-0245-2", "PMC9912977", "32112045"]}, {"Citation": "National Cancer Institute  Cancers by Body Location/System.  [(accessed on 9 February 2023)]; Available online:  https://www.cancer.gov/types/by-body-location#hematologicblood."}, {"Citation": "Arber D.A., Orazi A., Hasserjian R., Thiele J., Borowitz M.J., Le Beau M.M., Bloomfield C.D., Cazzola M., Vardiman J.W. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood J. Am. Soc. Hematol. 2016;127:2391\u20132405. doi: 10.1182/blood-2016-03-643544.", "ArticleIdList": ["10.1182/blood-2016-03-643544", "27069254"]}, {"Citation": "Swerdlow S.H., Campo E., Pileri S.A., Harris N.L., Stein H., Siebert R., Advani R., Ghielmini M., Salles G.A., Zelenetz A.D. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood J. Am. Soc. Hematol. 2016;127:2375\u20132390. doi: 10.1182/blood-2016-01-643569.", "ArticleIdList": ["10.1182/blood-2016-01-643569", "PMC4874220", "26980727"]}, {"Citation": "Yanada M., Naoe T. Acute myeloid leukemia in older adults. Int. J. Hematol. 2012;96:186\u2013193. doi: 10.1007/s12185-012-1137-3.", "ArticleIdList": ["10.1007/s12185-012-1137-3", "22791510"]}, {"Citation": "Chatterjee K., Zhang J., Honbo N., Karliner J.S. Doxorubicin cardiomyopathy. Cardiology. 2010;115:155\u2013162. doi: 10.1159/000265166.", "ArticleIdList": ["10.1159/000265166", "PMC2848530", "20016174"]}, {"Citation": "Brown T., Pilkington G., Bagust A., Boland A., Oyee J., Tudur-Smith C., Blundell M., Lai M., Saborido M., Greenhalgh J. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: A systematic review and economic evaluation. Health Technol. Assess. 2013;17:1\u2013278. doi: 10.3310/hta17060.", "ArticleIdList": ["10.3310/hta17060", "PMC4781689", "23886301"]}, {"Citation": "Lin S.R., Chang C.H., Hsu C.F., Tsai M.J., Cheng H., Leong M.K., Sung P.J., Chen J.C., Weng C.F. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. Br. J. Pharmacol. 2020;177:1409\u20131423. doi: 10.1111/bph.14816.", "ArticleIdList": ["10.1111/bph.14816", "PMC7056458", "31368509"]}, {"Citation": "Tabbara I.A., Zimmerman K., Morgan C., Nahleh Z. Allogeneic hematopoietic stem cell transplantation: Complications and results. Arch. Intern. Med. 2002;162:1558\u20131566. doi: 10.1001/archinte.162.14.1558.", "ArticleIdList": ["10.1001/archinte.162.14.1558", "12123398"]}, {"Citation": "Wildes T.M., Rosko A., Tuchman S.A. Multiple myeloma in the older adult: Better prospects, more challenges. J. Clin. Oncol. 2014;32:2531. doi: 10.1200/JCO.2014.55.1028.", "ArticleIdList": ["10.1200/JCO.2014.55.1028", "PMC4129503", "25071143"]}, {"Citation": "Hainaut P., Plymoth A. Targeting the hallmarks of cancer: Towards a rational approach to next-generation cancer therapy. Cur. Opin. Oncol. 2013;25:50\u201351. doi: 10.1097/CCO.0b013e32835b651e.", "ArticleIdList": ["10.1097/CCO.0b013e32835b651e", "23150341"]}, {"Citation": "Gopal S., Wood W.A., Lee S.J., Shea T.C., Naresh K.N., Kazembe P.N., Casper C., Hesseling P.B., Mitsuyasu R.T. Meeting the challenge of hematologic malignancies in sub-Saharan Africa. Blood Am. Soc. Hematol. 2012;119:5078\u20135087. doi: 10.1182/blood-2012-02-387092.", "ArticleIdList": ["10.1182/blood-2012-02-387092", "PMC4507039", "22461494"]}, {"Citation": "Patel P., Hanson D.L., Sullivan P.S., Novak R.M., Moorman A.C., Tong T.C., Holmberg S.D., Brooks J.T., Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992\u20132003. Ann. Intern. Med. 2008;148:728\u2013736. doi: 10.7326/0003-4819-148-10-200805200-00005.", "ArticleIdList": ["10.7326/0003-4819-148-10-200805200-00005", "18490686"]}, {"Citation": "Thorley-Lawson D.A., Gross A. Persistence of the Epstein\u2013Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 2004;350:1328\u20131337. doi: 10.1056/NEJMra032015.", "ArticleIdList": ["10.1056/NEJMra032015", "15044644"]}, {"Citation": "Kafuko G.W., Burkitt D.P. Burkitt\u2019s lymphoma and malaria. Int. J. Cancer. 1970;6:1\u20139. doi: 10.1002/ijc.2910060102.", "ArticleIdList": ["10.1002/ijc.2910060102", "4319231"]}, {"Citation": "Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. GLOBOCAN 2008 v1. 2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. International Agency for Research on Cancer; Lyon, France: 2010."}, {"Citation": "Canel C., Moraes R.M., Dayan F.E., Ferreira D. Podophyllotoxin. Phytochemistry. 2000;54:115\u2013120. doi: 10.1016/S0031-9422(00)00094-7.", "ArticleIdList": ["10.1016/S0031-9422(00)00094-7", "10872202"]}, {"Citation": "Cirla A., Mann J. Combretastatins: From natural products to drug discovery. Nat. Prod. Rep. 2003;20:558\u2013564. doi: 10.1039/b306797c.", "ArticleIdList": ["10.1039/b306797c", "14700199"]}, {"Citation": "Clardy J., Walsh C. Lessons from natural molecules. Nature. 2004;432:829\u2013837. doi: 10.1038/nature03194.", "ArticleIdList": ["10.1038/nature03194", "15602548"]}, {"Citation": "Iweala E.E.J., Bankole E.O., Iheagwam F.N., Dania O.E., Ntite U.F. Cytotoxic assessment of Xylopia aethiopica [Dun.] A. on human prostate and breast cancer cell lines. TJNPR. 2020;4:1143\u20131146."}, {"Citation": "Yakubu O.F., Adebayo A.H., Dokunmu T.M., Zhang Y.J., Iweala E.E. Cytotoxic effects of compounds isolated from Ricinodendron heudelotii. Molecules. 2019;24:145. doi: 10.3390/molecules24010145.", "ArticleIdList": ["10.3390/molecules24010145", "PMC6337108", "30609707"]}, {"Citation": "Kim W., Lee W.-B., Lee J.-W., Min B.-I., Baek S.K., Lee H.S., Cho S.-H. Traditional herbal medicine as adjunctive therapy for breast cancer: A systematic review. Complement. Therap. Med. 2015;23:626\u2013632. doi: 10.1016/j.ctim.2015.03.011.", "ArticleIdList": ["10.1016/j.ctim.2015.03.011", "26275657"]}, {"Citation": "Kuo Y.-T., Liao H.-H., Chiang J.-H., Wu M.-Y., Chen B.-C., Chang C.-M., Yeh M.-H., Chang T.-T., Sun M.-F., Yeh C.-C. Complementary Chinese herbal medicine therapy improves survival of patients with pancreatic cancer in Taiwan: A nationwide population-based cohort study. Integr. Cancer Therap. 2018;17:411\u2013422. doi: 10.1177/1534735417722224.", "ArticleIdList": ["10.1177/1534735417722224", "PMC6041895", "28774207"]}, {"Citation": "Ouyang L., Luo Y., Tian M., Zhang S.Y., Lu R., Wang J.H., Kasimu R., Li X. Plant natural products: From traditional compounds to new emerging drugs in cancer therapy. Cell Prolif. 2014;47:506\u2013515. doi: 10.1111/cpr.12143.", "ArticleIdList": ["10.1111/cpr.12143", "PMC6496831", "25377084"]}, {"Citation": "Mutlu Altunda\u011f E., Y\u0131lmaz A.M., Ko\u00e7t\u00fcrk S., Taga Y., Yal\u00e7\u0131n A.S. Synergistic induction of apoptosis by quercetin and curcumin in chronic myeloid leukemia (K562) cells. Nutr. Cancer. 2018;70:97\u2013108. doi: 10.1080/01635581.2018.1380208.", "ArticleIdList": ["10.1080/01635581.2018.1380208", "29161179"]}, {"Citation": "Briguglio G., Costa C., Pollicino M., Giambo F., Catania S., Fenga C. Polyphenols in cancer prevention: New insights. Int. J. Funct. Nutri. 2020;1:9. doi: 10.3892/ijfn.2020.9.", "ArticleIdList": ["10.3892/ijfn.2020.9"]}, {"Citation": "Pojero F., Poma P., Spano V., Montalbano A., Barraja P., Notarbartolo M. Targeting multiple myeloma with natural polyphenols. Eur. J. Med. Chem. 2019;180:465\u2013485. doi: 10.1016/j.ejmech.2019.07.041.", "ArticleIdList": ["10.1016/j.ejmech.2019.07.041", "31330448"]}, {"Citation": "Ravishankar D., Rajora A.K., Greco F., Osborn H.M.I. Flavonoids as prospective compounds for anti-cancer therapy. Int. J. Biochem. Cell Biol. 2013;45:2821\u20132831. doi: 10.1016/j.biocel.2013.10.004.", "ArticleIdList": ["10.1016/j.biocel.2013.10.004", "24128857"]}, {"Citation": "Geng W., Guo X., Zhang L., Ma Y., Wang L., Liu Z., Ji H., Xiong Y. Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/\u03b2-catenin signaling pathway. Biomed. Pharmacother. 2018;107:484\u2013494. doi: 10.1016/j.biopha.2018.08.003.", "ArticleIdList": ["10.1016/j.biopha.2018.08.003", "30107344"]}, {"Citation": "Hsiao P.-C., Chang J.-H., Lee W.-J., Ku C.-C., Tsai M.-Y., Yang S.-F., Chien M.-H. The curcumin analogue, EF-24, triggers p38 MAPK-mediated apoptotic cell death via inducing PP2A-modulated ERK deactivation in human acute myeloid leukemia cells. Cancers. 2020;12:2163. doi: 10.3390/cancers12082163.", "ArticleIdList": ["10.3390/cancers12082163", "PMC7464750", "32759757"]}, {"Citation": "Maso V., Calgarotto A.K., Franchi G.C., Nowill A.E., Vassallo J., Saad S.T.O. Multitarget Effects of Quercetin in LeukemiaMultitarget Effects of Quercetin in Leukemia. Cancer Prev. Res. 2014;7:1240\u20131250. doi: 10.1158/1940-6207.CAPR-13-0383.", "ArticleIdList": ["10.1158/1940-6207.CAPR-13-0383", "25293876"]}, {"Citation": "Naimi A., Entezari A., Hagh M.F., Hassanzadeh A., Saraei R., Solali S. Quercetin sensitizes human myeloid leukemia KG-1 cells against TRAIL-induced apoptosis. J. Cell. Physiol. 2019;234:13233\u201313241. doi: 10.1002/jcp.27995.", "ArticleIdList": ["10.1002/jcp.27995", "30589076"]}, {"Citation": "Shi H., Li X.-Y., Chen Y., Zhang X., Wu Y., Wang Z.-X., Chen P.-H., Dai H.-Q., Feng J., Chatterjee S. Quercetin induces apoptosis via downregulation of vascular endothelial growth factor/Akt signaling pathway in acute myeloid leukemia cells. Front. Pharmacol. 2020;11:534171. doi: 10.3389/fphar.2020.534171.", "ArticleIdList": ["10.3389/fphar.2020.534171", "PMC7758733", "33362534"]}, {"Citation": "Bischoff S.C. Quercetin: Potentials in the prevention and therapy of disease. Curr. Opin. Clin. Nutr. Metab. Care. 2008;11:733\u2013740. doi: 10.1097/MCO.0b013e32831394b8.", "ArticleIdList": ["10.1097/MCO.0b013e32831394b8", "18827577"]}, {"Citation": "Wang W., Sun C., Mao L., Ma P., Liu F., Yang J., Gao Y. The biological activities, chemical stability, metabolism and delivery systems of quercetin: A review. Trends Food Sci. Technol. 2016;56:21\u201338. doi: 10.1016/j.tifs.2016.07.004.", "ArticleIdList": ["10.1016/j.tifs.2016.07.004"]}, {"Citation": "Due\u00f1as M., Gonz\u00e1lez-Manzano S., Gonz\u00e1lez-Param\u00e1s A., Santos-Buelga C. Anti-oxidant evaluation of O-methylated metabolites of catechin, epicatechin and quercetin. J. Pharm. Biomed. Anal. 2010;51:443\u2013449. doi: 10.1016/j.jpba.2009.04.007.", "ArticleIdList": ["10.1016/j.jpba.2009.04.007", "19442472"]}, {"Citation": "Ganesan S., Faris A.N., Comstock A.T., Wang Q., Nanua S., Hershenson M.B., Sajjan U.S. Quercetin inhibits rhinovirus replication in vitro and in vivo. Antivir. Res. 2012;94:258\u2013271. doi: 10.1016/j.antiviral.2012.03.005.", "ArticleIdList": ["10.1016/j.antiviral.2012.03.005", "PMC3360794", "22465313"]}, {"Citation": "Kleemann R., Verschuren L., Morrison M., Zadelaar S., van Erk M.J., Wielinga P.Y., Kooistra T. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis. 2011;218:44\u201352. doi: 10.1016/j.atherosclerosis.2011.04.023.", "ArticleIdList": ["10.1016/j.atherosclerosis.2011.04.023", "21601209"]}, {"Citation": "Kawahara T., Kawaguchi-Ihara N., Okuhashi Y., Itoh M., Nara N., Tohda S. Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res. 2009;29:4629\u20134632.", "ArticleIdList": ["20032413"]}, {"Citation": "Gokbulut A.A., Apohan E., Baran Y. Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest. Hematology. 2013;18:144\u2013150. doi: 10.1179/1607845412Y.0000000042.", "ArticleIdList": ["10.1179/1607845412Y.0000000042", "23432965"]}, {"Citation": "Calgarotto A.K., Maso V., Junior G.C.F., Nowill A.E., Vassallo J., Saad S.T.O. Anti-tumor activities of quercetin and green tea in xenografts of human leukemia HL60 cells. Sci. Rep. 2018;8:3459. doi: 10.1038/s41598-018-21516-5.", "ArticleIdList": ["10.1038/s41598-018-21516-5", "PMC5823936", "29472583"]}, {"Citation": "Niu G., Yin S., Xie S., Li Y., Nie D., Ma L., Wang X., Wu Y. Quercetin induces apoptosis by activating caspase-3 and regulating Bcl-2 and cyclooxygenase-2 pathways in human HL-60 cells. Acta Biochim. Biophys. Sin. 2011;43:30\u201337. doi: 10.1093/abbs/gmq107.", "ArticleIdList": ["10.1093/abbs/gmq107", "21173056"]}, {"Citation": "Spagnuolo C., Cerella C., Russo M., Chateauvieux S., Diederich M., Russo G.L. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. Br. J. Cancer. 2011;105:221\u2013230. doi: 10.1038/bjc.2011.229.", "ArticleIdList": ["10.1038/bjc.2011.229", "PMC3142809", "21750559"]}, {"Citation": "Chang J.L., Chow J.M., Chang J.H., Wen Y.C., Lin Y.W., Yang S.F., Lee W.J., Chien M.H. Quercetin simultaneously induces G0/G1-phase arrest and caspase-mediated crosstalk between apoptosis and autophagy in human leukemia HL-60 cells. Environ. Toxicol. 2017;32:1857\u20131868. doi: 10.1002/tox.22408.", "ArticleIdList": ["10.1002/tox.22408", "28251795"]}, {"Citation": "Olivas-Aguirre M., Torres-L\u00f3pez L., Pottosin I., Dobrovinskaya O. Phenolic compounds cannabidiol, curcumin and quercetin cause mitochondrial dysfunction and suppress acute lymphoblastic leukemia cells. Int. J. Mol. Sci. 2020;22:204. doi: 10.3390/ijms22010204.", "ArticleIdList": ["10.3390/ijms22010204", "PMC7795267", "33379175"]}, {"Citation": "Alvarez M.C., Maso V., Torello C.O., Ferro K.P., Saad S.T.O. The polyphenol quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes. Clin. Epigenet. 2018;10:139. doi: 10.1186/s13148-018-0563-3.", "ArticleIdList": ["10.1186/s13148-018-0563-3", "PMC6225654", "30409182"]}, {"Citation": "Claus R., Hackanson B., Poetsch A.R., Zucknick M., Sonnet M., Blagitko-Dorfs N., Hiller J., Wilop S., Br\u00fcmmendorf T.H., Galm O. Quantitative analyses of DAPK1 methylation in AML and MDS. Int. J. Cancer. 2012;131:E138\u2013E142. doi: 10.1002/ijc.26429.", "ArticleIdList": ["10.1002/ijc.26429", "PMC3463871", "21918973"]}, {"Citation": "Kristensen L.S., Treppendahl M.B., Asmar F., Girkov M.S., Nielsen H.M., Kjeldsen T.E., Ralfkiaer E., Hansen L.L., Gr\u00f8nb\u00e6k K. Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing. Sci. Rep. 2013;3:2789. doi: 10.1038/srep02789.", "ArticleIdList": ["10.1038/srep02789", "PMC3784959", "24071855"]}, {"Citation": "Youle R.J., Strasser A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat. Rev. Mol. Cell Bio. 2008;9:47\u201359. doi: 10.1038/nrm2308.", "ArticleIdList": ["10.1038/nrm2308", "18097445"]}, {"Citation": "Wang L., Zhang W., Ding Y., Xiu B., Li P., Dong Y., Zhu Q., Liang A. Up-regulation of VEGF and its receptor in refractory leukemia cells. Int. J. Clin. Exper. Pathol. 2015;8:5282.", "ArticleIdList": ["PMC4503100", "26191229"]}, {"Citation": "Lee W.-J., Hsiao M., Chang J.-L., Yang S.-F., Tseng T.-H., Cheng C.-W., Chow J.-M., Lin K.-H., Lin Y.-W., Liu C.-C. Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft. Arch. Toxicol. 2015;89:1103\u20131117. doi: 10.1007/s00204-014-1300-0.", "ArticleIdList": ["10.1007/s00204-014-1300-0", "25138434"]}, {"Citation": "Rahbaran M., Razeghian E. Anti-leukemic effects of the quercetin on human leukemia U937 cells mediated by down-regulation of Mcl-1, survivin, and XIAP. Ann. Cancer Res. Therap. 2021;29:55\u201361. doi: 10.4993/acrt.29.55.", "ArticleIdList": ["10.4993/acrt.29.55"]}, {"Citation": "Baron B.W., Thirman M.J., Giurcanu M.C., Baron J.M. Quercetin therapy for selected patients with PIM1 kinase-positive chronic lymphocytic leukemia/small lymphocytic lymphoma: A pilot study. Acta Haematol. 2018;139:132\u2013139. doi: 10.1159/000486361.", "ArticleIdList": ["10.1159/000486361", "29444501"]}, {"Citation": "Gan R.-Y., Li H.-B., Sui Z.-Q., Corke H. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Cri. Rev. Food Sci. Nutr. 2018;58:924\u2013941. doi: 10.1080/10408398.2016.1231168.", "ArticleIdList": ["10.1080/10408398.2016.1231168", "27645804"]}, {"Citation": "Cai Y.-Z., Sun M., Xing J., Luo Q., Corke H. Structure\u2013radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants. Life Sci. 2006;78:2872\u20132888. doi: 10.1016/j.lfs.2005.11.004.", "ArticleIdList": ["10.1016/j.lfs.2005.11.004", "16325868"]}, {"Citation": "Tipoe G.L., Leung T.M., Liong E.C., Lau T.Y.H., Fung M.L., Nanji A.A. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology. 2010;273:45\u201352. doi: 10.1016/j.tox.2010.04.014.", "ArticleIdList": ["10.1016/j.tox.2010.04.014", "20438794"]}, {"Citation": "Du G.-J., Zhang Z., Wen X.-D., Yu C., Calway T., Yuan C.-S., Wang C.-Z. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients. 2012;4:1679\u20131691. doi: 10.3390/nu4111679.", "ArticleIdList": ["10.3390/nu4111679", "PMC3509513", "23201840"]}, {"Citation": "Ghasemi-Pirbaluti M., Pourgheysari B., Shirzad H., Sourani Z., Beshkar P. The inhibitory effect of Epigallocatechin gallate on the viability of T lymphoblastic leukemia cells is associated with increase of caspase-3 level and Fas expression. Indian J. Hematol. Blood Transfus. 2018;34:253\u2013260. doi: 10.1007/s12288-017-0854-4.", "ArticleIdList": ["10.1007/s12288-017-0854-4", "PMC5884976", "29622866"]}, {"Citation": "Jokar M.H., Sedighi S., Moradzadeh M. A comparative study of anti-leukemic effects of kaempferol and epigallocatechin-3-gallate (EGCG) on human leukemia HL-60 cells. Avicenna J. Phytomed. 2021;11:314.", "ArticleIdList": ["PMC8264220", "34290963"]}, {"Citation": "Borutinskait\u0117 V., Virk\u0161ait\u0117 A., Gudelyt\u0117 G., Navakauskien\u0117 R. Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells. Leuk. Lymphoma. 2018;59:469\u2013478. doi: 10.1080/10428194.2017.1339881.", "ArticleIdList": ["10.1080/10428194.2017.1339881", "28641467"]}, {"Citation": "Zhang L., Chen Q.-S., Xu P.-P., Qian Y., Wang A.-H., Xiao D., Zhao Y., Sheng Y., Wen X.-Q., Zhao W.-L. Catechins induced acute promyelocytic leukemia cell apoptosis and triggered PML-RAR\u03b1 oncoprotein degradation. J. Hematol. Oncol. 2014;7:1\u20139. doi: 10.1186/s13045-014-0075-3.", "ArticleIdList": ["10.1186/s13045-014-0075-3", "PMC4197244", "25270015"]}, {"Citation": "Torello C.O., Shiraishi R.N., Della Via F.I., de Castro T.C.L., Longhini A.L., Santos I., Bombeiro A.L., Silva C.L.A., de Souza Queiroz M.L., Rego E.M. Reactive oxygen species production triggers green tea-induced anti-leukaemic effects on acute promyelocytic leukaemia model. Cancer Lett. 2018;414:116\u2013126. doi: 10.1016/j.canlet.2017.11.006.", "ArticleIdList": ["10.1016/j.canlet.2017.11.006", "29129782"]}, {"Citation": "Kogan S., Ward J., Anver M., Berman J., Brayton C., Cardiff R., Carter J., de Coronado S., Downing J., Fredrickson T. Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood. 2002;100:238\u2013245. doi: 10.1182/blood.V100.1.238.", "ArticleIdList": ["10.1182/blood.V100.1.238", "12070033"]}, {"Citation": "Della Via F.I., Shiraishi R.N., Santos I., Ferro K.P., Salazar-Terreros M.J., Franchi Junior G.C., Rego E.M., Saad S.T.O., Torello C.O. (\u2013)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1. Sci. Rep. 2021;11:9103. doi: 10.1038/s41598-021-88478-z.", "ArticleIdList": ["10.1038/s41598-021-88478-z", "PMC8079435", "33907248"]}, {"Citation": "Elmore S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007;35:495\u2013516. doi: 10.1080/01926230701320337.", "ArticleIdList": ["10.1080/01926230701320337", "PMC2117903", "17562483"]}, {"Citation": "Xiao X., Jiang K., Xu Y., Peng H., Wang Z., Liu S., Zhang G. (\u2212)-Epigallocatechin-3-gallate induces cell apoptosis in chronic myeloid leukaemia by regulating Bcr/Abl-mediated p38-MAPK/JNK and JAK 2/STAT 3/AKT signalling pathways. Clin. Exper. Pharmacol. Physiol. 2019;46:126\u2013136. doi: 10.1111/1440-1681.13037.", "ArticleIdList": ["10.1111/1440-1681.13037", "30251267"]}, {"Citation": "Kroemer G., Martin S.J. Caspase-independent cell death. Nat. Med. 2005;11:725\u2013730. doi: 10.1038/nm1263.", "ArticleIdList": ["10.1038/nm1263", "16015365"]}, {"Citation": "Moradzadeh M., Roustazadeh A., Tabarraei A., Erfanian S., Sahebkar A. Epigallocatechin-3-gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML-RAR\u03b1 and HDAC1. Phytother. Res. 2018;32:471\u2013479. doi: 10.1002/ptr.5990.", "ArticleIdList": ["10.1002/ptr.5990", "29193405"]}, {"Citation": "Goker B., Caliskan C., Caglar H.O., Kayabasi C., Balci T., Tepedelen B.E., Aygunes D., Susluer S.Y., Mutlu Z., Selvi N. Synergistic effect of ponatinib and epigallocatechin-3-gallate induces apoptosis in chronic myeloid leukemia cells through altering expressions of cell cycle regulatory genes. J. BUON Off. J. Balk. Union Oncol. 2014;19:992\u2013998.", "ArticleIdList": ["25536607"]}, {"Citation": "Wang Y.-N., Wang J., Yang H.-N., Zhang B.-L., Zhang P., Sun P.-Y., Zhang N., Wang Y., Sheng J., Wang X.-J. The oxidation of (\u2212)-epigallocatechin-3-gallate inhibits T-cell acute lymphoblastic leukemia cell line HPB-ALL via the regulation of Notch1 expression. RSC Adv. 2020;10:1679\u20131684. doi: 10.1039/C9RA08459B.", "ArticleIdList": ["10.1039/C9RA08459B", "PMC9047518", "35494663"]}, {"Citation": "Westphal S., McGeary A., Rudloff S., Wilke A., Penack O. The green tea catechin epigallocatechin gallate ameliorates graft-versus-host disease. PLoS ONE. 2017;12:e0169630. doi: 10.1371/journal.pone.0169630.", "ArticleIdList": ["10.1371/journal.pone.0169630", "PMC5245838", "28103249"]}, {"Citation": "Detampel P., Beck M., Kr\u00e4henb\u00fchl S., Huwyler J. Drug interaction potential of resveratrol. Drug Metab. Rev. 2012;44:253\u2013265. doi: 10.3109/03602532.2012.700715.", "ArticleIdList": ["10.3109/03602532.2012.700715", "22788578"]}, {"Citation": "Shaito A., Posadino A.M., Younes N., Hasan H., Halabi S., Alhababi D., Al-Mohannadi A., Abdel-Rahman W.M., Eid A.H., Nasrallah G.K. Potential adverse effects of resveratrol: A literature review. Int. J. Mol. Sci. 2020;21:2084. doi: 10.3390/ijms21062084.", "ArticleIdList": ["10.3390/ijms21062084", "PMC7139620", "32197410"]}, {"Citation": "Bo S., Ciccone G., Castiglione A., Gambino R., De Michieli F., Villois P., Durazzo M., Cavallo-Perin P., Cassader M. Anti-inflammatory and anti-oxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Cur. Med. Chem. 2013;20:1323\u20131331. doi: 10.2174/0929867311320100009.", "ArticleIdList": ["10.2174/0929867311320100009", "23298135"]}, {"Citation": "Colica C., Milanovi\u0107 M., Mili\u0107 N., Aiello V., De Lorenzo A., Abenavoli L. A systematic review on natural anti-oxidant properties of resveratrol. Nat. Product Comm. 2018;13:1934578X1801300923."}, {"Citation": "Xiao Q., Zhu W., Feng W., Lee S.S., Leung A.W., Shen J., Gao L., Xu C. A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy. Front. Pharmacol. 2019;9:1534. doi: 10.3389/fphar.2018.01534.", "ArticleIdList": ["10.3389/fphar.2018.01534", "PMC6333683", "30687096"]}, {"Citation": "Hsieh T.C., Wu J.M. Resveratrol: Biological and pharmaceutical properties as anti-cancer molecule. Biofactors. 2010;36:360\u2013369. doi: 10.1002/biof.105.", "ArticleIdList": ["10.1002/biof.105", "PMC3655417", "20623546"]}, {"Citation": "Jiao G.E., Yan L.I.U., Qiang L.I., Xia G.U.O., Ling G.U., Gui Z., Zhu Y.P. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK. Biomed. Environ. Sci. 2013;26:902\u2013911.", "ArticleIdList": ["24331535"]}, {"Citation": "Li Q., Yue Y., Chen L., Xu C., Wang Y., Du L., Xue X., Liu Q., Wang Y., Fan F. Resveratrol sensitizes carfilzomib-induced apoptosis via promoting oxidative stress in multiple myeloma cells. Front. Pharmacol. 2018;9:334. doi: 10.3389/fphar.2018.00334.", "ArticleIdList": ["10.3389/fphar.2018.00334", "PMC5961230", "29867453"]}, {"Citation": "Canturk Z., Dikmen M., Artagan O., Ozarda M.G., Ozturk N. Cytotoxic Effects of Resveratrol, Rutin and Rosmarinic Acid on ARH\u201377 Human (Multiple Myeloma) Cell Line. Nat. Prod. Comm. 2016;11:1934578X1601101007. doi: 10.1177/1934578X1601101007.", "ArticleIdList": ["10.1177/1934578X1601101007", "30549595"]}, {"Citation": "Ma R., Yu D., Peng Y., Yi H., Wang Y., Cheng T., Shi B., Yang G., Lai W., Wu X., et al. Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cells. Acta Biochim. Biophys. Sin. 2021;53:775\u2013783. doi: 10.1093/abbs/gmab042.", "ArticleIdList": ["10.1093/abbs/gmab042", "33891090"]}, {"Citation": "Yu X., Li Z., Zheng H., Chan M.T., Wu W.K.K. NEAT 1: A novel cancer-related long non-coding RNA. Cell Prolif. 2017;50:e12329. doi: 10.1111/cpr.12329.", "ArticleIdList": ["10.1111/cpr.12329", "PMC6529067", "28105699"]}, {"Citation": "Zhou W., Wang S., Ying Y., Zhou R., Mao P. miR-196b/miR-1290 participate in the anti-tumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia. Oncol. Rep. 2017;37:1075\u20131083. doi: 10.3892/or.2016.5321.", "ArticleIdList": ["10.3892/or.2016.5321", "28000876"]}, {"Citation": "Hussain A.R., Uddin S., Bu R., Khan O.S., Ahmed S.O., Ahmed M., Al-Kuraya K.S. Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines. PLoS ONE. 2011;6:e24703. doi: 10.1371/journal.pone.0024703.", "ArticleIdList": ["10.1371/journal.pone.0024703", "PMC3171480", "21931821"]}, {"Citation": "Yan Y., Gao Y.-Y., Liu B.-Q., Niu X.-F., Zhuang Y., Wang H.-Q. Resveratrol-induced cytotoxicity in human Burkitt\u2019s lymphoma cells is coupled to the unfolded protein response. BMC Cancer. 2010;10:445. doi: 10.1186/1471-2407-10-445.", "ArticleIdList": ["10.1186/1471-2407-10-445", "PMC2931494", "20723265"]}, {"Citation": "Muchtar E., Gertz M.A., Magen H. A practical review on carfilzomib in multiple myeloma. Eur. J. Haematol. 2016;96:564\u2013577. doi: 10.1111/ejh.12749.", "ArticleIdList": ["10.1111/ejh.12749", "26893241"]}, {"Citation": "Wang L., Wang C., Jia Y., Liu Z., Shu X., Liu K. Resveratrol increases anti-proliferative activity of bestatin through downregulating P-glycoprotein expression via inhibiting PI3K/Akt/mTOR pathway in K562/ADR cells. J. Cell. Biochem. 2016;117:1233\u20131239. doi: 10.1002/jcb.25407.", "ArticleIdList": ["10.1002/jcb.25407", "26460589"]}, {"Citation": "Kweon S.H., Song J.H., Kim T.S. Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression. Biochem. Biophys. Res. Comm. 2010;395:104\u2013110. doi: 10.1016/j.bbrc.2010.03.147.", "ArticleIdList": ["10.1016/j.bbrc.2010.03.147", "20350534"]}, {"Citation": "Wu E.J., Goussetis D.J., Beauchamp E., Kosciuczuk E.M., Altman J.K., Eklund E.A., Platanias L.C. Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors. Cancer Biol. Therap. 2014;15:473\u2013478. doi: 10.4161/cbt.27824.", "ArticleIdList": ["10.4161/cbt.27824", "PMC3979825", "24496081"]}, {"Citation": "Akram M., Shahab-Uddin A.A., Usmanghani K., Hannan A., Mohiuddin E., Asif M. Curcuma longa and curcumin: A review article. Rom. J. Biol. Plant Biol. 2010;55:65\u201370."}, {"Citation": "Mahady G.B., Pendland S.L., Yun G., Lu Z.Z. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res. 2002;22:4179\u20134181.", "ArticleIdList": ["12553052"]}, {"Citation": "Vera-Ramirez L., P\u00e9rez-Lopez P., Varela-Lopez A., Ramirez-Tortosa M., Battino M., Quiles J.L. Curcumin and liver disease. BioFactors. 2013;39:88\u2013100. doi: 10.1002/biof.1057.", "ArticleIdList": ["10.1002/biof.1057", "23303639"]}, {"Citation": "Iweala E.J., Uche M.E., Dike E.D., Etumnu L.R., Dokunmu T.M., Oluwapelumi A.E., Okoro B.C., Dania O.E., Adebayo A.H., Ugbogu E.A. Curcuma longa (Turmeric): Ethnomedicinal uses, phytochemistry, pharmacological activities and toxicity profiles-A review. Pharmacol. Res.-Modern Chinese Med. 2023;22:100222. doi: 10.1016/j.prmcm.2023.100222.", "ArticleIdList": ["10.1016/j.prmcm.2023.100222"]}, {"Citation": "Liao W., Xiang W., Wang F.-F., Wang R., Ding Y. Curcumin inhibited growth of human melanoma A375 cells via inciting oxidative stress. Biomed. Pharmacother. 2017;95:1177\u20131186. doi: 10.1016/j.biopha.2017.09.026.", "ArticleIdList": ["10.1016/j.biopha.2017.09.026", "28926928"]}, {"Citation": "Jiang A.-J., Jiang G., Li L.-T., Zheng J.-N. Curcumin induces apoptosis through mitochondrial pathway and caspases activation in human melanoma cells. Mol. Bio. Rep. 2015;42:267\u2013275. doi: 10.1007/s11033-014-3769-2.", "ArticleIdList": ["10.1007/s11033-014-3769-2", "25262359"]}, {"Citation": "Mishra D., Singh S., Narayan G. Curcumin induces apoptosis in Pre-B acute lymphoblastic leukemia cell lines via PARP-1 cleavage. Asian Pac. J. Cancer Prev. 2016;17:3865\u20133869.", "ArticleIdList": ["27644631"]}, {"Citation": "Shah K., Mirza S., Desai U., Jain N., Rawal R. Synergism of curcumin and cytarabine in the down regulation of multi-drug resistance genes in acute myeloid leukemia. Anticancer Agents Med. Chem. 2016;16:128\u2013135. doi: 10.2174/1871520615666150817115718.", "ArticleIdList": ["10.2174/1871520615666150817115718", "26278546"]}, {"Citation": "Pimentel-Guti\u00e9rrez H.J., Bobadilla-Morales L., Barba-Barba C.C., Ortega-De-La-Torre C., S\u00e1nchez-Zubieta F.A., Corona-Rivera J.R., Gonz\u00e1lez-Quezada B.A., Armend\u00e1riz-Borunda J.S., Silva-Cruz R., Corona-Rivera A. Curcumin potentiates the effect of chemotherapy against acute lymphoblastic leukemia cells via downregulation of NF-\u03baB. Oncol. Lett. 2016;12:4117\u20134124. doi: 10.3892/ol.2016.5217.", "ArticleIdList": ["10.3892/ol.2016.5217", "PMC5104245", "27895780"]}, {"Citation": "Pesakhov S., Nachliely M., Barvish Z., Aqaqe N., Schwartzman B., Voronov E., Sharoni Y., Studzinski G.P., Fishman D., Danilenko M. Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid. Oncotarget. 2016;7:31847. doi: 10.18632/oncotarget.7240.", "ArticleIdList": ["10.18632/oncotarget.7240", "PMC5077981", "26870993"]}, {"Citation": "Papie\u017c M.A., Krzy\u015bciak W., Szade K., Bukowska-Strakov\u00e1 K., Kozakowska M., Hajduk K., Bystrowska B., Dulak J., Jozkowicz A. Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species. Drug Des. Develop. Therap. 2016;10:557. doi: 10.2147/DDDT.S92687.", "ArticleIdList": ["10.2147/DDDT.S92687", "PMC4745860", "26893544"]}, {"Citation": "Ramakrishna R., Diamond T.H., Alexander W., Manoharan A., Golombick T. Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy. Clin. Case Rep. 2020;8:739\u2013744. doi: 10.1002/ccr3.2735.", "ArticleIdList": ["10.1002/ccr3.2735", "PMC7141712", "32274049"]}, {"Citation": "Golombick T., Diamond T.H., Manoharan A., Ramakrishna R. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. Am. J. Hematol. 2012;87:455\u2013460. doi: 10.1002/ajh.23159.", "ArticleIdList": ["10.1002/ajh.23159", "22473809"]}, {"Citation": "Golombick T., Diamond T.H., Manoharan A., Ramakrishna R. Long term use of curcumin in two smoldering multiple myeloma patients. J. Hematol. Malig. 2013;3:18\u201332. doi: 10.5430/jhm.v3n1p18.", "ArticleIdList": ["10.5430/jhm.v3n1p18"]}, {"Citation": "Golombick T., Diamond T.H., Manoharan A., Ramakrishna R. B-cell disorders and curcumin. Integr. Cancer Therap. 2017;16:255\u2013257. doi: 10.1177/1534735415622013.", "ArticleIdList": ["10.1177/1534735415622013", "PMC5759937", "26674787"]}, {"Citation": "Guo Y., Shan Q., Gong Y., Lin J., Shi F., Shi R., Yang X. Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells. Die Pharm. Int. J. Pharm. Sci. 2014;69:229\u2013233.", "ArticleIdList": ["24716415"]}, {"Citation": "Yang C.-W., Chang C.-L., Lee H.-C., Chi C.-W., Pan J.-P., Yang W.-C. Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK Pathways. BMC Complement. Altern. Med. 2012;12:22. doi: 10.1186/1472-6882-12-22.", "ArticleIdList": ["10.1186/1472-6882-12-22", "PMC3342909", "22443687"]}, {"Citation": "Zhu G.-H., Dai H.-P., Shen Q., Ji O., Zhang Q., Zhai Y.-L. Curcumin induces apoptosis and suppresses invasion through MAPK and MMP signaling in human monocytic leukemia SHI-1 cells. Pharma. Biol. 2016;54:1303\u20131311. doi: 10.3109/13880209.2015.1060508.", "ArticleIdList": ["10.3109/13880209.2015.1060508", "26134921"]}, {"Citation": "Zhu G., Shen Q., Jiang H., Ji O., Zhu L., Zhang L. Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells in vivo by altering MAPK and MMP signalling. Pharma. Biol. 2020;58:25\u201334. doi: 10.1080/13880209.2019.1701042.", "ArticleIdList": ["10.1080/13880209.2019.1701042", "PMC6968541", "31854220"]}, {"Citation": "Li Y., Domina A., Lim G., Chang T., Zhang T. Evaluation of curcumin, a natural product in turmeric, on Burkitt lymphoma and acute myeloid leukemia cancer stem cell markers. Fut. Oncol. 2018;14:2353\u20132360. doi: 10.2217/fon-2018-0202.", "ArticleIdList": ["10.2217/fon-2018-0202", "30139269"]}, {"Citation": "Pironi A.M., de Ara\u00fajo P.R., Fernandes M.A., Salgado H.R.N., Chorilli M. Characteristics, biological properties and analytical methods of ursolic acid: A review. Crit. Rev. Anal. Chem. 2018;48:86\u201393. doi: 10.1080/10408347.2017.1390425.", "ArticleIdList": ["10.1080/10408347.2017.1390425", "29039968"]}, {"Citation": "Mendes V.I., Bartholomeusz G.A., Ayres M., Gandhi V., Salvador J.A. Synthesis and cytotoxic activity of novel A-ring cleaved ursolic acid derivatives in human non-small cell lung cancer cells. Eur. J. Med. Chem. 2016;123:317\u2013331. doi: 10.1016/j.ejmech.2016.07.045.", "ArticleIdList": ["10.1016/j.ejmech.2016.07.045", "PMC5652311", "27484517"]}, {"Citation": "Mlala S., Oyedeji A.O., Gondwe M., Oyedeji O.O. Ursolic acid and its derivatives as bioactive agents. Molecules. 2019;24:2751. doi: 10.3390/molecules24152751.", "ArticleIdList": ["10.3390/molecules24152751", "PMC6695944", "31362424"]}, {"Citation": "Wu P.-P., Zhang B.-J., Cui X.-P., Yang Y., Jiang Z.-Y., Zhou Z.-H., Zhong Y.-Y., Mai Y.-Y., Ouyang Z., Chen H.-S. Synthesis and biological evaluation of novel ursolic acid analogues as potential \u03b1-glucosidase inhibitors. Sci. Rep. 2017;7:45578. doi: 10.1038/srep45578.", "ArticleIdList": ["10.1038/srep45578", "PMC5372089", "28358057"]}, {"Citation": "Uto T., Sakamoto A., Tung N.H., Fujiki T., Kishihara K., Oiso S., Kariyazono H., Morinaga O., Shoyama Y. Anti-proliferative activities and apoptosis induction by triterpenes derived from Eriobotrya japonica in human leukemia cell lines. Int. J. Mol. Sci. 2013;14:4106\u20134120. doi: 10.3390/ijms14024106.", "ArticleIdList": ["10.3390/ijms14024106", "PMC3588088", "23429195"]}, {"Citation": "Kaewthawee N., Brimson S. The effects of ursolic acid on cytokine production via the MAPK pathways in leukemic T-cells. EXCLI J. 2013;12:102.", "ArticleIdList": ["PMC4531796", "26417220"]}, {"Citation": "Lin Z., Jiang J., Liu X.-S. Ursolic acid-mediated apoptosis of K562 cells involves Stat5/Akt pathway inhibition through the induction of Gfi-1. Sci. Rep. 2016;6:33358. doi: 10.1038/srep33358.", "ArticleIdList": ["10.1038/srep33358", "PMC5025887", "27634378"]}, {"Citation": "Zhang T., He Y.-M., Wang J.-S., Shen J., Xing Y.-Y., Xi T. Ursolic acid induces HL60 monocytic differentiation and upregulates C/EBP\u03b2 expression by ERK pathway activation. Anticancer Drugs. 2011;22:158\u2013165. doi: 10.1097/CAD.0b013e3283409673.", "ArticleIdList": ["10.1097/CAD.0b013e3283409673", "20948428"]}, {"Citation": "Gao N., Cheng S., Budhraja A., Gao Z., Chen J., Liu E.H., Huang C., Chen D., Yang Z., Liu Q. Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway. Br. J. Pharmacol. 2012;165:1813\u20131826. doi: 10.1111/j.1476-5381.2011.01684.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01684.x", "PMC3372832", "21950524"]}, {"Citation": "Lin D., Zhang R., Feng T., Chen L., Ying-Ying X., Tao X. Ursolic acid induces U937 cells differentiation by PI3K/Akt pathway activation. Chin. J. Nat. Med. 2014;12:15\u201319.", "ArticleIdList": ["24484591"]}, {"Citation": "Wu B., Wang X., Chi Z.-f., Hu R., Zhang R., Yang W., Liu Z.-G. Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway. Arch. Pharmacal Res. 2012;35:543\u2013548. doi: 10.1007/s12272-012-0318-1.", "ArticleIdList": ["10.1007/s12272-012-0318-1", "22477202"]}, {"Citation": "Song G.R., Park Y.J.C.S.J., Shin S., Lee G., Choi H.J., Lee D.Y., Song G.-Y., Oh S. Root Bark of Morus alba L. and Its Bioactive Ingredient, Ursolic Acid, Suppress the Proliferation of Multiple Myeloma Cells by Inhibiting Wnt/\u03b2-Catenin Pathway. J. Microbiol. Biotechnol. 2021;31:1559\u20131567. doi: 10.4014/jmb.2109.09002.", "ArticleIdList": ["10.4014/jmb.2109.09002", "PMC9706038", "34584036"]}, {"Citation": "Shen M., Wang D., Sennari Y., Zeng Z., Baba R., Morimoto H., Kitamura N., Nakanishi T., Tsukada J., Ueno M. Pentacyclic triterpenoid ursolic acid induces apoptosis with mitochondrial dysfunction in adult T-cell leukemia MT-4 cells to promote surrounding cell growth. Med. Oncol. 2022;39:118. doi: 10.1007/s12032-022-01707-x.", "ArticleIdList": ["10.1007/s12032-022-01707-x", "35674939"]}, {"Citation": "Brentnall M., Rodriguez-Menocal L., De Guevara R.L., Cepero E., Boise L.H. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 2013;14:32. doi: 10.1186/1471-2121-14-32.", "ArticleIdList": ["10.1186/1471-2121-14-32", "PMC3710246", "23834359"]}, {"Citation": "Shan J.-Z., Xuan Y.-Y., Ruan S.-Q., Sun M. Proliferation-inhibiting and apoptosis-inducing effects of ursolic acid and oleanolic acid on multi-drug resistance cancer cells in vitro. Chin. J. Integr. Med. 2011;17:607\u2013611. doi: 10.1007/s11655-011-0815-y.", "ArticleIdList": ["10.1007/s11655-011-0815-y", "21826595"]}, {"Citation": "Adhami V.M., Syed D.N., Khan N., Mukhtar H. Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. Biochem. Pharmacol. 2012;84:1277\u20131281. doi: 10.1016/j.bcp.2012.07.012.", "ArticleIdList": ["10.1016/j.bcp.2012.07.012", "PMC3813433", "22842629"]}, {"Citation": "Kim H.J., Kim S.H., Yun J.-M. Fisetin inhibits hyperglycemia-induced proinflammatory cytokine production by epigenetic mechanisms. Evid. Based Complement. Altern. Med. 2012;2012:639469. doi: 10.1155/2012/639469.", "ArticleIdList": ["10.1155/2012/639469", "PMC3539716", "23320034"]}, {"Citation": "Zhang Y., Zong B., Wang X., Zhu Y., Hu L., Li P., Zhang A., Chen H., Liu M., Tan C. Fisetin lowers Streptococcus suis serotype 2 pathogenicity in mice by inhibiting the hemolytic activity of suilysin. Front. Microbiol. 2018;9:1723. doi: 10.3389/fmicb.2018.01723.", "ArticleIdList": ["10.3389/fmicb.2018.01723", "PMC6077255", "30105012"]}, {"Citation": "Adan A., Baran Y. Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling. Tumor Biol. 2016;37:5781\u20135795. doi: 10.1007/s13277-015-4118-3.", "ArticleIdList": ["10.1007/s13277-015-4118-3", "26408178"]}, {"Citation": "Tsai Y.-H., Lin J.-J., Ma Y.-S., Peng S.-F., Huang A.-C., Huang Y.-P., Fan M.-J., Lien J.-C., Chung J.-G. Fisetin inhibits cell proliferation through the induction of G0/G1 phase arrest and caspase-3-mediated apoptosis in mouse leukemia cells. Am. J. Chin. Med. 2019;47:841\u2013863. doi: 10.1142/S0192415X19500447.", "ArticleIdList": ["10.1142/S0192415X19500447", "31096772"]}, {"Citation": "Jang K.Y., Jeong S.-J., Kim S.-H., Jung J.H., Kim J.-H., Koh W., Chen C.-Y., Kim S.-H. Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells. Cancer Lett. 2012;319:197\u2013202. doi: 10.1016/j.canlet.2012.01.008.", "ArticleIdList": ["10.1016/j.canlet.2012.01.008", "22261340"]}, {"Citation": "Adan A., Baran Y. The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks. Tumor Biol. 2015;36:8973\u20138984. doi: 10.1007/s13277-015-3597-6.", "ArticleIdList": ["10.1007/s13277-015-3597-6", "26081618"]}, {"Citation": "Li F., Sethi G. Targeting transcription factor NF-\u03baB to overcome chemoresistance and radioresistance in cancer therapy. Biochim. Biophys. Acta (BBA) Rev. Cancer. 2010;1805:167\u2013180. doi: 10.1016/j.bbcan.2010.01.002.", "ArticleIdList": ["10.1016/j.bbcan.2010.01.002", "20079806"]}, {"Citation": "Zhao X., Liu X., Su L. Parthenolide induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung cancer cells. J. Exp. Clin. Cancer Res. 2014;33:3. doi: 10.1186/1756-9966-33-3.", "ArticleIdList": ["10.1186/1756-9966-33-3", "PMC3892099", "24387758"]}, {"Citation": "Klimaszewska-Wi\u015bniewska A., Grzanka D., Czajkowska P., Ha\u0142as-Wi\u015bniewska M., Dur\u015blewicz J., Antosik P., Grzanka A., Gagat M. Cellular and molecular alterations induced by low-dose fisetin in human chronic myeloid leukemia cells. Int. J. Oncol. 2019;55:1261\u20131274. doi: 10.3892/ijo.2019.4889.", "ArticleIdList": ["10.3892/ijo.2019.4889", "PMC6831210", "31638196"]}, {"Citation": "Kashyap D., Mondal R., Tuli H.S., Kumar G., Sharma A.K. Molecular targets of gambogic acid in cancer: Recent trends and advancements. Tumor Biol. 2016;37:12915\u201312925. doi: 10.1007/s13277-016-5194-8.", "ArticleIdList": ["10.1007/s13277-016-5194-8", "27448303"]}, {"Citation": "Chen R., Zhang H., Liu P., Wu X., Chen B. Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma. J. Cancer. 2017;8:839. doi: 10.7150/jca.17657.", "ArticleIdList": ["10.7150/jca.17657", "PMC5381173", "28382147"]}, {"Citation": "Shi X., Chen X., Li X., Lan X., Zhao C., Liu S., Huang H., Liu N., Liao S., Song W. Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation. Clin. Cancer Res. 2014;20:151\u2013163. doi: 10.1158/1078-0432.CCR-13-1063.", "ArticleIdList": ["10.1158/1078-0432.CCR-13-1063", "PMC3938960", "24334603"]}, {"Citation": "Shi X., Lan X., Chen X., Zhao C., Li X., Liu S., Huang H., Liu N., Zang D., Liao Y. Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition. Sci. Rep. 2015;5:9694. doi: 10.1038/srep09694.", "ArticleIdList": ["10.1038/srep09694", "PMC4894437", "25853502"]}, {"Citation": "Chen J., Zhou M., Zhang Q., Xu J., Ouyang J. Anti-cancer effect and apoptosis induction of gambogic acid in human leukemia cell line K562 in vitro. Med. Sci. Monit. 2015;21:1604.", "ArticleIdList": ["PMC4463775", "26049398"]}, {"Citation": "Li W., Wang S., Feng J., Xiao Y., Xue X., Zhang H., Wang Y., Liang X. Structure elucidation and NMR assignments for curcuminoids from the rhizomes of Curcuma longa. Magn. Reson. Chem. 2009;47:902\u2013908. doi: 10.1002/mrc.2478.", "ArticleIdList": ["10.1002/mrc.2478", "19569074"]}, {"Citation": "Liu P., Wu X., Dai L., Ge Z., Gao C., Zhang H., Wang F., Zhang X., Chen B. Gambogenic acid exerts anti-tumor activity in hypoxic multiple myeloma cells by regulation of miR-21. J. Cancer. 2017;8:3278. doi: 10.7150/jca.19290.", "ArticleIdList": ["10.7150/jca.19290", "PMC5665045", "29158801"]}, {"Citation": "Wang F., Zhang W., Guo L., Bao W., Jin N., Liu R., Liu P., Wang Y., Guo Q., Chen B. Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1\u03b1/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells. Cancer Sci. 2014;105:1063\u20131070. doi: 10.1111/cas.12458.", "ArticleIdList": ["10.1111/cas.12458", "PMC4317858", "24890366"]}, {"Citation": "Leone E., Morelli E., Di Martino M.T., Amodio N., Foresta U., Gull\u00e0 A., Rossi M., Neri A., Giordano A., Munshi N.C. Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth Anti-tumor Activity of mir-21 Inhibitors in Multiple Myeloma. Clin. Cancer Res. 2013;19:2096\u20132106. doi: 10.1158/1078-0432.CCR-12-3325.", "ArticleIdList": ["10.1158/1078-0432.CCR-12-3325", "PMC4147955", "23446999"]}, {"Citation": "Wang T., Du J., Kong D., Yang G., Zhou Q., You F., Lin Y., Wang Y. Gambogic acid inhibits proliferation and induces apoptosis of human acute T-cell leukemia cells by inducing autophagy and downregulating \u03b2-catenin signaling pathway: Mechanisms underlying the effect of Gambogic acid on T-ALL cells. Oncol. Rep. 2020;44:1747\u20131757. doi: 10.3892/or.2020.7726.", "ArticleIdList": ["10.3892/or.2020.7726", "32945501"]}, {"Citation": "Pandey M.K., Kale V.P., Song C., Sung S.-s., Sharma A.K., Talamo G., Dovat S., Amin S.G. Gambogic acid inhibits multiple myeloma mediated osteoclastogenesis through suppression of chemokine receptor CXCR4 signaling pathways. Exp. Hematol. 2014;42:883\u2013896. doi: 10.1016/j.exphem.2014.07.261.", "ArticleIdList": ["10.1016/j.exphem.2014.07.261", "25034231"]}, {"Citation": "Rajkumar S.V., Dimopoulos M.A., Palumbo A., Blade J., Merlini G., Mateos M.-V., Kumar S., Hillengass J., Kastritis E., Richardson P. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u2013e548. doi: 10.1016/S1470-2045(14)70442-5.", "ArticleIdList": ["10.1016/S1470-2045(14)70442-5", "25439696"]}, {"Citation": "Chen Y., Hui H., Li Z., Wang H.-M., You Q.-D., Lu N. Gambogic acid induces growth inhibition and differentiation via upregulation of p21waf1/cip1 expression in acute myeloid leukemia cells. J. Asian Nat. Prod. Res. 2014;16:1000\u20131008. doi: 10.1080/10286020.2014.918108.", "ArticleIdList": ["10.1080/10286020.2014.918108", "24835506"]}, {"Citation": "Yang L.-J., Chen Y., He J., Yi S., Wen L., Zhao S., Cui G.-H. Effects of gambogic acid on the activation of caspase-3 and downregulation of SIRT1 in RPMI-8226 multiple myeloma cells via the accumulation of ROS. Oncol. Lett. 2012;3:1159\u20131165. doi: 10.3892/ol.2012.634.", "ArticleIdList": ["10.3892/ol.2012.634", "PMC3389632", "22783411"]}, {"Citation": "Brinker A.M., Ma J., Lipsky P.E., Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae) Phytochemistry. 2007;68:732\u2013766. doi: 10.1016/j.phytochem.2006.11.029.", "ArticleIdList": ["10.1016/j.phytochem.2006.11.029", "PMC3867260", "17250858"]}, {"Citation": "Kannaiyan R., Hay H.S., Rajendran P., Li F., Shanmugam M.K., Vali S., Abbasi T., Kapoor S., Sharma A., Kumar A.P. Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-\u03baB and STAT3 regulated gene products in multiple myeloma cells. Br. J. Pharmacol. 2011;164:1506\u20131521. doi: 10.1111/j.1476-5381.2011.01449.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01449.x", "PMC3221104", "21506956"]}, {"Citation": "Ng S.W., Chan Y., Chellappan D.K., Madheswaran T., Zeeshan F., Chan Y.L., Collet T., Gupta G., Oliver B.G., Wark P. Molecular modulators of celastrol as the keystones for its diverse pharmacological activities. Biomed. Pharmacother. 2019;109:1785\u20131792. doi: 10.1016/j.biopha.2018.11.051.", "ArticleIdList": ["10.1016/j.biopha.2018.11.051", "30551432"]}, {"Citation": "Mateos M.-V., Ocio E.M., San Miguel J.F. Novel generation of agents with proven clinical activity in multiple myeloma. Semin. Oncol. 2013;40:618\u2013633. doi: 10.1053/j.seminoncol.2013.07.005.", "ArticleIdList": ["10.1053/j.seminoncol.2013.07.005", "24135407"]}, {"Citation": "Vincenz L., J\u00e4ger R., O\u2019Dwyer M., Samali A. Endoplasmic Reticulum Stress and the Unfolded Protein Response: Targeting the Achilles Heel of Multiple MyelomaUPR in Multiple Myeloma. Mol. Cancer Ther. 2013;12:831\u2013843. doi: 10.1158/1535-7163.MCT-12-0782.", "ArticleIdList": ["10.1158/1535-7163.MCT-12-0782", "23729400"]}, {"Citation": "Zhong Y.-l., Xu G.-j., Huang S., Zhao L., Zeng Y., Xiao X.-f., An J.-l., Liu J., Yang T. Celastrol induce apoptosis of human multiple myeloma cells involving inhibition of proteasome activity. Eur. J. Pharmacol. 2019;853:184\u2013192. doi: 10.1016/j.ejphar.2019.03.036.", "ArticleIdList": ["10.1016/j.ejphar.2019.03.036", "30928629"]}, {"Citation": "Lu Z., Jin Y., Qiu L., Lai Y., Pan J. Celastrol, a novel HSP90 inhibitor, depletes Bcr\u2013Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation. Cancer Lett. 2010;290:182\u2013191. doi: 10.1016/j.canlet.2009.09.006.", "ArticleIdList": ["10.1016/j.canlet.2009.09.006", "19819619"]}, {"Citation": "Carter B.Z., Mak P.Y., Mu H., Zhou H., Mak D.H., Schober W., Leverson J.D., Zhang B., Bhatia R., Huang X. Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells. Sci. Transl. Med. 2016;8:ra117\u2013ra355. doi: 10.1126/scitranslmed.aag1180.", "ArticleIdList": ["10.1126/scitranslmed.aag1180", "PMC5111086", "27605552"]}, {"Citation": "Yang K., Fu L.-W. Mechanisms of resistance to BCR\u2013ABL TKIs and the therapeutic strategies: A review. Crit. Rev. Oncol. Hematol. 2015;93:277\u2013292. doi: 10.1016/j.critrevonc.2014.11.001.", "ArticleIdList": ["10.1016/j.critrevonc.2014.11.001", "25500000"]}, {"Citation": "Ni H., Zhao W., Kong X., Li H., Ouyang J. NF-kappa B modulation is involved in celastrol induced human multiple myeloma cell apoptosis. PLoS ONE. 2014;9:e95846. doi: 10.1371/journal.pone.0095846.", "ArticleIdList": ["10.1371/journal.pone.0095846", "PMC3995890", "24755677"]}, {"Citation": "Shanmugam M.K., Ahn K.S., Lee J.H., Kannaiyan R., Mustafa N., Manu K.A., Siveen K.S., Sethi G., Chng W.J., Kumar A.P. Celastrol attenuates the invasion and migration and augments the anti-cancer effects of bortezomib in a xenograft mouse model of multiple myeloma. Front. Pharmacol. 2018;9:365. doi: 10.3389/fphar.2018.00365.", "ArticleIdList": ["10.3389/fphar.2018.00365", "PMC5943600", "29773987"]}, {"Citation": "Tozawa K., Sagawa M., Kizaki M. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-\u03baB pathway. Int. J. Oncol. 2011;39:1117\u20131122.", "ArticleIdList": ["21850367"]}, {"Citation": "Davenport A., Frezza M., Shen M., Ge Y., Huo C., Chan T.H., Dou Q.P. Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells. Int. J. Mol. Med. 2010;25:465\u2013470.", "ArticleIdList": ["PMC3304460", "20127053"]}, {"Citation": "Zhang X., Yang J., Chen M., Li L., Huan F., Li A., Liu Y., Xia Y., Duan J.-a., Ma S. Metabolomics profiles delineate uridine deficiency contributes to mitochondria-mediated apoptosis induced by celastrol in human acute promyelocytic leukemia cells. Oncotarget. 2016;7:46557. doi: 10.18632/oncotarget.10286.", "ArticleIdList": ["10.18632/oncotarget.10286", "PMC5216817", "27374097"]}, {"Citation": "Padmavathi G., Rathnakaram S.R., Monisha J., Bordoloi D., Roy N.K., Kunnumakkara A.B. Potential of butein, a tetrahydroxychalcone to obliterate cancer. Phytomedicine. 2015;22:1163\u20131171. doi: 10.1016/j.phymed.2015.08.015.", "ArticleIdList": ["10.1016/j.phymed.2015.08.015", "26598915"]}, {"Citation": "Padmavathi G., Roy N.K., Bordoloi D., Arfuso F., Mishra S., Sethi G., Bishayee A., Kunnumakkara A.B. Butein in health and disease: A comprehensive review. Phytomedicine. 2017;25:118\u2013127. doi: 10.1016/j.phymed.2016.12.002.", "ArticleIdList": ["10.1016/j.phymed.2016.12.002", "28190465"]}, {"Citation": "Tang Y.-L., Huang L.-B., Lin W.-H., Wang L.-N., Tian Y., Shi D., Wang J., Qin G., Li A., Liang Y.-N. Butein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathway. Oncotarget. 2016;7:18651. doi: 10.18632/oncotarget.7624.", "ArticleIdList": ["10.18632/oncotarget.7624", "PMC4951317", "26919107"]}, {"Citation": "Shi J., Zhang L., Shen A., Zhang J., Wang Y., Zhao Y., Zou L., Ke Q., He F., Wang P. Clinical and biological significance of forkhead class box O 3a expression in glioma: Mediation of glioma malignancy by transcriptional regulation of p27kip1. J. Neuro-Oncol. 2010;98:57\u201369. doi: 10.1007/s11060-009-0045-8.", "ArticleIdList": ["10.1007/s11060-009-0045-8", "19911116"]}, {"Citation": "Yan F., Liao R., Lin S., Deng X., Little P.J., Zheng W. Forkhead box protein O3 suppresses uveal melanoma development by increasing the expression of Bcl-2-like protein 11 and cyclin-dependent kinase inhibitor 1B. Mol. Med. Rep. 2018;17:3109\u20133114. doi: 10.3892/mmr.2017.8215.", "ArticleIdList": ["10.3892/mmr.2017.8215", "29257235"]}, {"Citation": "Moon D.-O., Kim M.-O., Lee J.-D., Choi Y.H., Kim G.-Y. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells. Cancer Lett. 2009;286:172\u2013179. doi: 10.1016/j.canlet.2009.05.028.", "ArticleIdList": ["10.1016/j.canlet.2009.05.028", "19560862"]}, {"Citation": "Ishikawa C., Senba M., Mori N. Butein inhibits NF-\u03baB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma. Int. J. Oncol. 2017;51:633\u2013643. doi: 10.3892/ijo.2017.4026.", "ArticleIdList": ["10.3892/ijo.2017.4026", "28586006"]}, {"Citation": "Woo S.M., Choi Y.K., Kim A.J., Cho S.G., Ko S.G. p53 causes butein-mediated apoptosis of chronic myeloid leukemia cells. Mol. Med. Rep. 2016;13:1091\u20131096. doi: 10.3892/mmr.2015.4672.", "ArticleIdList": ["10.3892/mmr.2015.4672", "PMC4732842", "26676515"]}, {"Citation": "Kim N. Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis inducing ligand (TRAIL) Arch. Pharmacal Res. 2008;31:1179\u20131186. doi: 10.1007/s12272-001-1286-2.", "ArticleIdList": ["10.1007/s12272-001-1286-2", "18806962"]}, {"Citation": "Hong X.Y., Jm W., Luo X.Q., Liu K., Zhou W.J., Zhang G.W. Research progress of inhibitory effects of polyphenolic compounds on xanthine oxidase. Food Mach. 2021;37:1\u20138. doi: 10.13652/j.issn.1003-5788.2021.02.001.", "ArticleIdList": ["10.13652/j.issn.1003-5788.2021.02.001"]}, {"Citation": "Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010;2:1231\u20131246. doi: 10.3390/nu2121231.", "ArticleIdList": ["10.3390/nu2121231", "PMC3257627", "22254006"]}, {"Citation": "Zhang H., Tsao R. Dietary polyphenols, oxidative stress and anti-oxidant and anti-inflammatory effects. Curr. Opin. Food Sci. 2016;8:33\u201342. doi: 10.1016/j.cofs.2016.02.002.", "ArticleIdList": ["10.1016/j.cofs.2016.02.002"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "20"}, {"Year": "2023", "Month": "2", "Day": "12"}, {"Year": "2023", "Month": "2", "Day": "15"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "11", "Minute": "51"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "11", "Minute": "50"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "1", "Minute": "26"}, {"Year": "2023", "Month": "6", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["37511797", "PMC10381774", "10.3390/life13071422", "life13071422"]}}], "PubmedBookArticle": []}